Neuberger Berman Group’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
RA
FWIA
BC
Neuberger Berman Group's ANGO Position: Q1 2018 in Review
Neuberger Berman Group sold out of AngioDynamics (ANGO) in Q1 2018, closing a stake of 19,193 shares — an estimated $319K sold.
Neuberger Berman Group first reported a position in ANGO in Q2 2017 and held it in 3 quarters. The position peaked at $328K in Q3 2017. 164 funds tracked by Wall St. Rank hold ANGO as of Q1 2018.
- Neuberger Berman Group reported no remaining AngioDynamics position as of Q1 2018 after selling out during the quarter.
- Neuberger Berman Group sold 19,193 AngioDynamics shares in Q1 2018, an estimated $319K.
- Neuberger Berman Group first reported a position in AngioDynamics in Q2 2017 and held it in 3 quarters.
- Neuberger Berman Group's AngioDynamics position peaked at $328K in Q3 2017.
- 164 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2018.
Based on Neuberger Berman Group's 13F filing for Q1 2018, filed 8 May 2018.